גאלבוס 50 מ"ג

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

VILDAGLIPTIN 50 MG

Disponible desde:

NOVARTIS PHARMA SERVICES AG

Código ATC:

A10BH02

formulario farmacéutico:

TABLETS

Vía de administración:

PER OS

Fabricado por:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Grupo terapéutico:

VILDAGLIPTIN

indicaciones terapéuticas:

Galvus is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• As monotherapy, if diet and exercise are not sufficient, or• In combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose.As triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. Galvus is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.

Fecha de autorización:

2013-11-01